Agenda


Day 1 – March 19th


8:00-8:20- Registration, Breakfast

8:20-8:45- Welcome Remarks (Tulane University School of Medicine: Greg Bix, Director, CNRC; Lee Hamm, Dean, School of Medicine)

8:45-9:30- The year that was: Clinical and scientific advancements in translational stroke in 2019 (S. Thomas Carmichael, UCLA)

9:30-10:15- There and back again: Lessons from the natalizumab experience (Kyra Becker, University of Washington)

10:15-10:45- Coffee Break

10:45-11:30- Consideration of systemic responses in stroke (Eng Lo, Harvard Medical School)

11:30-12:15- Sex, microbiome and stroke (Louise McCullough, University of Texas, Houston)

12:15-12:30- Tulane Brain Institute (Jill Daniel, Director, Tulane Brain Institute)

12:30-1:45- Networking Lunch at Themed Tables (Tulane University: Greg Bix, Xiaoying Wang, Prasad Katakam, David Busija; University of Wisconsin: Raghu Vemuganti)

3:00- Board Buses for Afternoon Activities


AFTERNOON DESTINATION ACTIVITY


3:30-5:00- Mardi Gras World tour

5:15-8:00- Tour & Dinner at Tulane President’s house


Day 2 – March 20th


8:00-8:30- Breakfast and Announcements (Tulane University School of Medicine: Greg Bix, Director, CNRC)

8:30-8:45- Research at Tulane University (Giovanni Piedimonte, Vice President for Research, Tulane University)

8:45-9:30- Beyond motor recovery: Post-stroke dementia (Marion Buckwalter, Stanford University)

9:30-10:15- Consideration of ageing in ischemic stroke (Miguel Perez Pinzon, University of Miami)

10:15-10:45- Coffee Break

11:00-12:15- Interactive Brainstorming – what’s wrong with translational stroke research and how can we fix it? (Cenk Ayata, Harvard Medical School)

12:15-12:30- Research at Tulane School of Medicine (Patrice Delafontaine, Executive Dean, Tulane School of Medicine)

12:30-1:30- Lunch seminar – How to translate science to therapy from an Industry perspective (Gary Gage, Stream Biomedical)

1:30-4:00- Workgroups for paper publication


Participants are invited to remain for the afternoon to help draft possible publications from the Workshop. 

Groups will form around particular topics, discuss recommendations and concrete methods for moving the field forward. 

Writing groups will be formed to continue the work after the meeting.


The following subjects will be discussed in three workgroups:

  • Novel methods and protocols in ischemic stroke
  • Stroke biomarkers
  • Drug re-purposing in ischemic stroke treatment